Cargando…

Ventilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality

Background and objectives: High mortality and healthcare costs area associated with ventilator-associated pneumonia (VAP) due to Acinetobacter baumannii (A. baumannii). The data concerning the link between multidrug-resistance of A. baumannii strains and outcomes remains controversial. Therefore, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Čiginskienė, Aušra, Dambrauskienė, Asta, Rello, Jordi, Adukauskienė, Dalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410055/ https://www.ncbi.nlm.nih.gov/pubmed/30781896 http://dx.doi.org/10.3390/medicina55020049

Ejemplares similares

Clinical Features and Outcomes of Monobacterial and Polybacterial Episodes of Ventilator-Associated Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii
por: Adukauskiene, Dalia, et al.
Publicado: (2022)

Clinical Features and Outcomes of VAP Due to Multidrug-Resistant Klebsiella spp.: A Retrospective Study Comparing Monobacterial and Polybacterial Episodes
por: Adukauskiene, Dalia, et al.
Publicado: (2023)

Associations between β-Lactamase Types of Acinetobacter baumannii and Antimicrobial Resistance
por: Černiauskienė, Kristina, et al.
Publicado: (2023)

Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia
por: Inchai, Juthamas, et al.
Publicado: (2015)

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)

Predictors of Occurrence and 30-Day Mortality for Co-Infection of Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii
por: Lv, Dongmei, et al.
Publicado: (2022)

Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii
por: Kanchanasuwan, Siripen, et al.
Publicado: (2021)

Retrospective Assessment of Ventilator-Associated Pneumonias due to Acinetobacter baumannii in an Oncology Hospital
por: Canturan, Sevil Yesim, et al.
Publicado: (2021)

2557. Development of Rabbit Models of Ventilator-Associated Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Petraitis, Vidmantas, et al.
Publicado: (2023)

Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
por: Kim, Chung-Jong, et al.
Publicado: (2022)

Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Acinetobacter baumannii Bacteremia?
por: Wang, Yung-Chih, et al.
Publicado: (2020)

Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
por: Hsieh, Yu-Chia, et al.
Publicado: (2020)

Combined Rifampin and Sulbactam Therapy for Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Pediatric Patients
por: Chen, Jinlan, et al.
Publicado: (2018)

Comparative Respiratory Tract Microbiome Between Carbapenem-Resistant Acinetobacter baumannii Colonization and Ventilator Associated Pneumonia
por: Xiao, Tingting, et al.
Publicado: (2022)

Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia
por: Chiang, Tsung-Ta, et al.
Publicado: (2022)

Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality
por: Li, Yu jun, et al.
Publicado: (2017)

Aging exacerbates mortality of Acinetobacter baumannii pneumonia and reduces the efficacies of antibiotics and vaccine
por: Gu, Hao, et al.
Publicado: (2018)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection
por: de Gouvêa, Erika Ferraz, et al.
Publicado: (2012)

338 Prevalence, Mortality and Outcomes of Antibiotic Therapy of Multi-Drug Resistant Acinetobacter baumannii
por: Lapensee, Kenneth T., et al.
Publicado: (2014)

The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19
por: AliMohammadi, Ali, et al.
Publicado: (2023)

1855. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
por: Lee, Chan Mi, et al.
Publicado: (2022)

The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19
por: AliMohammadi, Ali, et al.
Publicado: (2023)

Corrigendum: Comparative respiratory tract microbiome between carbapenem-resistant Acinetobacter baumannii colonization and ventilator associated pneumonia
por: Xiao, Tingting, et al.
Publicado: (2022)

Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients
por: Shojaei, Lida, et al.
Publicado: (2016)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
por: Demirdal, Tuna, et al.
Publicado: (2016)

Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia
por: Son, Hyo-Ju, et al.
Publicado: (2020)

Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Multi-drug resistant Acinetobacter ventilator-associated pneumonia
por: Shete, Vishal B., et al.
Publicado: (2010)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

Acinetobacter baumannii Antibiotic Resistance Mechanisms
por: Kyriakidis, Ioannis, et al.
Publicado: (2021)

Multidrug-Resistant Acinetobacter baumannii in Jordan
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023)

High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit
por: Bai, Xiang-Rong, et al.
Publicado: (2020)

Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia
por: Park, Se Yoon, et al.
Publicado: (2013)

Subsequent Multidrug-Resistant Bacteremia Is a Risk Factor for Short-Term Mortality of Patients with Ventilator-Associated Pneumonia Caused by Acinetobacter baumannii in Intensive Care Unit: A Multicenter Experience
por: Ju, Mo-Han, et al.
Publicado: (2018)

Acinetobacter baumannii Infection in Prior ICU Bed Occupants Is an Independent Risk Factor for Subsequent Cases of Ventilator-Associated Pneumonia
por: Tsakiridou, Eirini, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gv73djo367evakn75mtc3jequj